Tissue Therapies
HOME TECHNOLOGY INVESTORS ALLIANCES COMPANY
CONTACT

COMPANY

BACKGROUND

THE TEAM

THE BOARD

 - ROGER CLARKE

- STEVEN MERCER

- GREG BAYNTON

- DONALD HOME

- DAVID GARDINER

- ROBERT BAXTER

- KEITH HARDING

- DRUMMOND McKENZIE
HOME COMPANY BOARD OF DIRECTORS   
BOARD OF DIRECTORS ::

CHAIRMAN: ROGER CLARKE
Mr Roger Clarke has over 30 years commercial experience, principally in the investment banking industry.

EXECUTIVE DIRECTOR: STEVEN MERCER
Dr Mercer brings considerable international expertise to Tissue Therapies following a successful career with multinational companies.

DIRECTOR: GREG BAYNTON
Mr Greg Baynton is Managing Director of Orbit Capital, a private investment bank and holder of an Australian Financial Services Licence.


DIRECTOR: DONALD HOME
Donald Home has over 20 years high technology health industry experience.


NON-EXECUTIVE DIRECTOR: PROFESSOR DAVID GARDINER
For the past 30 years, Proessor David Gardiner has been a Barrister-at-Law for the Supreme and High Courts of Australia.


SCIENTIFIC ADVISOR TO THE BOARD: PROFESSOR ROBERT BAXTER
Professor Robert Baxter is a leading expert in proteins that regulate cell growth and metabolism, the insulin-like growth factors and their binding proteins.


CLINICAL ADVISOR TO THE BOARD: KEITH HARDING
Professor Harding is recognised as one of the leading expert wound care researchers and clinicians in the world today.


COMPANY SECRETARY: DRUMMOND McKENZIE
Mr Drummond McKenzie is a Chartered Accountant and is the Chief Finance Officer and Company Secretary of an Australian insurance company.





© 2007 TISSUE THERAPIES LTD